Hospital Universitario Dr. Jose E. Gonzalez
Clinical trials sponsored by Hospital Universitario Dr. Jose E. Gonzalez, explained in plain language.
-
New combo aims to boost transplant success in tough lymphoma
Disease control Recruiting nowThis study tests whether a lower dose of the drug epcoritamab, combined with two chemotherapy drugs (gemcitabine and oxaliplatin), can shrink tumors in people with diffuse large B-cell lymphoma that has come back or not responded to prior treatment. The 10 participants must be el…
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated May 26, 2026 04:03 UTC
-
New combo offers hope for tough leukemia cases
Disease control Recruiting nowThis study tests a new drug combination for people with acute lymphoblastic leukemia (ALL) that has come back or not responded to standard treatment. The approach adds a low dose of venetoclax (a targeted drug) and itraconazole (to boost its effect) to a standard chemotherapy reg…
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated May 26, 2026 03:58 UTC
-
Weight-Loss drug semaglutide takes on psoriasis in new trial
Disease control Recruiting nowThis study tests whether adding semaglutide (a drug used for diabetes and weight loss) to a standard topical cream can improve psoriasis and reduce inflammation. About 62 adults with plaque psoriasis who are overweight or have type 2 diabetes will receive either semaglutide or a …
Phase: PHASE4 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated May 26, 2026 03:53 UTC